Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
Br J Dermatol, 2020.
Yiu ZZN, Mason KJ, Hampton PJ, Reynolds NJ, Smith CH, Lunt M, Griffiths CEM, Warren RB; BADBIR Study Group.
Read publication: Br J Dermatol
Related
Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR
Application of information theoretic feature selection and machine learning methods for the developm...
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab a...
Contact Us
Find Us
The University of Manchester
First Floor Bright Building
Manchester Science Park
Manchester
M15 6GZ
0 Comments